Palm oil conference finds no consistent heart risk from consumption

A Palm Conversations International India 2026 conference has concluded that existing cardiovascular evidence shows no consistent association between palm oil consumption and heart disease or stroke, while acknowledging study limitations. Hosted by the Malaysian Palm Oil Council, the event marked the first India edition of a forum that brings together researchers, healthcare professionals and policymakers to discuss emerging science on palm oil and its potential health relevance. Malaysia counts India as one of its largest palm oil export markets and has been deepening scientific and trade ties with the country.

A review of 4,515 scientific citations presented at the meeting found palm oil’s semi-solid structure allows functionality without partial hydrogenation, distinguishing it from industrial trans fats. Experts at the conference also examined palm-derived bioactive compounds such as tocotrienols and palm phenolics for their potential relevance to non-communicable diseases, stressing these remain an evolving research area not ready for clinical use. Support came from the Indian Medical Association, the International Association of Dietitians for Metabolic Health and Nutrition and the Oil Technologists’ Association of India.